Stocktoria
Personalis, Inc. PSNL
Nasdaq · XNAS · stock · Services-Medical Laboratories · website · IPO 2019-06-20
Personalis, Inc. financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $69.6M | $84.6M | $73.5M | $65.0M | $85.5M |
| R&D expense | $50.3M | $48.9M | $64.8M | $64.9M | $49.3M |
| SG&A expense | $53.6M | $46.2M | $49.7M | $64.0M | $47.7M |
| Operating income | -$88.1M | -$68.3M | -$109.9M | -$115.5M | -$65.4M |
| Interest expense | $205,000 | $24,000 | $110,000 | $201,000 | $184,000 |
| Income tax | $21,000 | $18,000 | $83,000 | $40,000 | $14,000 |
| Net income | -$81.3M | -$81.3M | -$108.3M | -$113.3M | -$65.2M |
| EPS (diluted) | $-0.91 | $-1.37 | $-2.25 | $-2.48 | $-1.49 |
| Operating cash flow | -$74.9M | -$45.1M | -$56.3M | -$70.2M | -$70.8M |
| Free cash flow | -$79.5M | -$46.8M | -$67.2M | -$120.1M | -$81.9M |
| Cash & equivalents | $124.2M | $91.4M | $57.0M | $89.1M | $105.6M |
| Total assets | $334.2M | $270.3M | $225.1M | $292.7M | $396.5M |
| Total liabilities | $73.0M | $67.3M | $95.7M | $74.6M | $86.2M |
| Shareholders' equity | $261.2M | $203.0M | $129.4M | $218.1M | $310.3M |
Source: SEC EDGAR filings · CIK 0001527753 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.